🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase I/II study for previously untreated subjects with advanced ...
Status
Terminated
Location
City of Hope
Start Date
2015-06-04
Trial ID
NCT02382406
Treatments Being Tested
Methodology: This is a controlled, randomized, multicenter open-label Phas...
Status
Unknown
Location
Hospital El Pilar
Start Date
2020-12-01
Trial ID
NCT04537130
Treatments Being Tested
Levetiracetam is the commonly preferred anti-seizure medicine in patients w...
Status
Recruiting
Location
Manipal Academy of Higher Education
Start Date
2024-07-04
Trial ID
NCT06442748
Treatments Being Tested
The investigators aim to evaluate the non-inferiority of administering toci...
Status
Not Yet Recruiting
Location
CHU de Nice
Start Date
2026-06-01
Trial ID
NCT07582185
Treatments Being Tested
The purpose of this study is to assess the efficacy and safety of pembroliz...
Status
Recruiting
Location
Banner MD Anderson Cancer Center ( Site 0001)
Start Date
2019-12-19
Trial ID
NCT04165070
This is a Phase I/IIa, multicenter study designed to evaluate the safety, t...
Status
Active Not Recruiting
Location
No. 1 Shuaifuyuan, Wangfujing, Dongcheng District
Start Date
2025-08-14
Trial ID
NCT07777211
Treatments Being Tested
This Phase 2, open-label, randomized study in non-small-cell lung cancer (N...
Status
Recruiting
Location
Pioneer Research Center, LLC
Start Date
2024-09-26
Trial ID
NCT06463665
Treatments Being Tested
In this study, we combine Nab-PTX, S-1 and sintilimab as adjuvant regimen t...
Status
Unknown
Location
Department of Surgery, Ruijin Hospital
Start Date
2021-03-01
Trial ID
NCT04781413
Treatments Being Tested
This is a Phase 1b/2, open-label, dose escalation, dose expansion and dose ...
Status
Recruiting
Location
Honor Health Research Institute
Start Date
2022-06-15
Trial ID
NCT05405595
The goal of this Phase I/II observational and interventional platform study...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-01-01
Trial ID
NCT07307053